Medrobotics, which makes a robot-assisted endoscopic device, closed on $26 million in Series E money it said will be used to seek FDA approval and to support the product's anticipated launch in Europe and the U.S.
Existing shareholders in the Raynham, MA-based company and "undisclosed new investors" took part in the new round of financing, the company said in a release. According to the SEC, the company raised $21.3 million of a $26 million share offering last September.
Previous investors have included Hercules Technology Growth Capital.
The company's Flex System received a CE mark in March. The device is touted as the first robot-assisted flexible endoscopic platform that, using a single entrance site on the body, allows surgeons to navigate around anatomical features and access hard-to-reach locations.
"It extends the capability of surgeons to reach around corners and operate in hard-to-reach and confined spaces," said Medrobotics CEO Samuel Straface in a statement.
- read the release